About Quantum Surgical
Quantum Surgical is a company based in Montpellier (France) founded in 2010 by Fernand Badano, Sophie Roca, Lucien Blondel, and Bertin Nahum. Quantum Surgical has raised $98 million across 4 funding rounds from investors including Caisse D Epargne, European Investment Bank and Bpifrance. Quantum Surgical has completed 1 acquisition, including NeuWave. Quantum Surgical offers products and services including Epione Robotic Platform. Quantum Surgical operates in a competitive market with competitors including Accuray, CyberKnife, Focal One and MDC, among others.
- Headquarter Montpellier, France
- Founders Fernand Badano, Sophie Roca, Lucien Blondel, Bertin Nahum
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Quantum Surgical Sas
-
Annual Revenue
$1.36 M (USD)22as on Dec 31, 2023
-
Net Profit
-$14.35 M (USD)-14as on Dec 31, 2023
-
EBITDA
-$16.24 M (USD)-14as on Dec 31, 2023
-
Total Equity Funding
$98 M (USD)
in 4 rounds
-
Latest Funding Round
$32.52 M (USD), Debt – Conventional
Mar 27, 2024
-
Investors
Caisse D Epargne
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quantum Surgical
Quantum Surgical offers a comprehensive portfolio of products and services, including Epione Robotic Platform.
Robotic system for planning and executing tumor ablation in cancer treatment.
People of Quantum Surgical
Unlock access to complete
Funding Insights of Quantum Surgical
Quantum Surgical has successfully raised a total of $98M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $32.52 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Quantum Surgical
Quantum Surgical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Caisse D Epargne, European Investment Bank and Bpifrance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Locked | Locked | Locked | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked | |
|
Corporate consultancy, advisory, and funding services are provided to businesses.
|
Locked | Locked | Locked |
Investor details for Quantum Surgical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quantum Surgical
Quantum Surgical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NeuWave.
Investment portfolio details for Quantum Surgical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microwave ablation systems for soft tissue and cancer are developed.
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Quantum Surgical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Quantum Surgical
Detailed financials for Quantum Surgical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quantum Surgical Comparisons
Peer comparison for Quantum Surgical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quantum Surgical
Quantum Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accuray, CyberKnife, Focal One and MDC, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of AI-based robotic radiosurgery planning and delivery systems
|
|
| Locked | Locked | Locked |
Develops and supplies advanced robotic devices for targeted cancer radiotherapy worldwide.
|
|
| Locked | Locked | Locked |
Non-invasive prostate ablation devices are developed via HIFU technology.
|
|
| Locked | Locked | Locked |
Medical devices for cancer diagnosis and treatment are developed.
|
Detailed competitors of Quantum Surgical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quantum Surgical
Complete news archive for Quantum Surgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quantum Surgical
Quantum Surgical was founded in 2010 and raised its 1st funding round 8 years after it was founded.
Quantum Surgical is headquartered in Montpellier, France. It is registered at Montpellier, Occitanie, France.
Bertin Nahum is the current CEO of Quantum Surgical. They have also founded this company.
Quantum Surgical is a funded company, having raised a total of $98M across 4 funding rounds to date.
Annual revenue of Quantum Surgical is $1.36M as on Dec 31, 2023.
Quantum Surgical was founded in 2010 in Montpellier, France, and operates in the medtech sector focused on surgical robotics. The Epione robotic platform is offered to support percutaneous ablation therapy, targeting liver cancer and inoperable tumors in the abdomen and lungs. Difficult-to-reach tumors are treated at early stages without open surgery, enabling precise interventions by physicians in oncology applications.
Quantum Surgical offers Epione Robotic Platform.
Quantum Surgical has made 1 acquisition, including NeuWave.
Quantum Surgical has 4 investors. Key investors include Caisse D Epargne, European Investment Bank, Bpifrance, and Ally Bridge Group.